(Q39637025)

13 September 2017

1 reference

title

Clinical pharmacokinetics of the newer antibacterial 4-quinolones (English)

1 reference

13 September 2017

0 references

1 reference

M Neuman

1

1 reference

13 September 2017

1 February 1988

1 reference

Clinical Pharmacokinetics

13 September 2017

1 reference

13 September 2017

14

1 reference

13 September 2017

96-121

1 reference

13 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-198814020-00003

13 September 2017

0 references

cites work

Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli

1 reference

12 December 2020

Elimination of enoxacin in renal disease

1 reference

12 December 2020

Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans

1 reference

12 December 2020

Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function

1 reference

12 December 2020

Recent advances in pharmaceutical chemistry. The 4-quinolone antibiotics

1 reference

12 December 2020

Multiple-dose ciprofloxacin kinetics in normal subjects

1 reference

12 December 2020

Serum and sputum concentrations of enoxacin after single oral dosing in a clinical and bacteriological study

1 reference

12 December 2020

The effect of the 4-quinolone enoxacin on plasma theophylline concentrations

1 reference

12 December 2020

Intraphagocytic Bactericidal Activity of Bacterial DNA Gyrase Inhibitors against <i>Serratia marcescens</i>

1 reference

12 December 2020

The pharmacokinetics and tissue penetration of norfloxacin

1 reference

12 December 2020

Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers

1 reference

12 December 2020

Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin

1 reference

12 December 2020

Enoxacin raises plasma theophylline concentrations

1 reference

12 December 2020

Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin in cystic fibrosis

1 reference

12 December 2020

Pharmacokinetics and tissue penetration of enoxacin

1 reference

12 December 2020

Ciprofloxacin distribution in prostatic tissue and fluid following oral administration

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin tablets in renal failure; influence of haemodialysis

1 reference

12 December 2020

Ciprofloxacin in plasma and peritoneal dialysate after oral therapy in patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

The mode of action of 4-quinolones and possible mechanisms of resistance

1 reference

12 December 2020

Uptake of ciprofloxacin by human neutrophils

1 reference

12 December 2020

Cross resistance of quinolone derivatives in gram-negative bacteria.

1 reference

12 December 2020

In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.

1 reference

12 December 2020

Pharmacokinetics of Ciprofloxacin in the Elderly

1 reference

12 December 2020

Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy

1 reference

12 December 2020

Single and multiple dose pharmacokinetics of ciprofloxacin

1 reference

12 December 2020

Ciprofloxacin pharmacokinetics in patients with cystic fibrosis

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients

1 reference

12 December 2020

Transfer kinetics of pefloxacin into cerebro-spinal fluid after one hour i.v. infusion of 400 mg in man.

1 reference

12 December 2020

Diffusion of enoxacin into the cerebrospinal fluid in dogs with healthy meninges and with experimental meningitis.

1 reference

12 December 2020

Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora

1 reference

12 December 2020

Enoxacin concentration in human prostatic tissue after oral administration

1 reference

12 December 2020

Metabolism and disposition of amifloxacin in laboratory animals

1 reference

12 December 2020

Dose- and sex-independent disposition of ciprofloxacin

1 reference

12 December 2020

Renal elimination of sulfo-ciprofloxacin, a new metabolite of ciprofloxacin

1 reference

12 December 2020

Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers

1 reference

12 December 2020

The pharmacokinetics of enoxacin in elderly patients

1 reference

12 December 2020

Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans

1 reference

12 December 2020

Ciprofloxacin concentrations in tonsils following a single intravenous infusion

1 reference

12 December 2020

The pharmacokinetics of ciprofloxacin in patients with impaired renal function

1 reference

12 December 2020

Pharmacokinetics of a single oral dose of ofloxacin in patients with renal failure.

1 reference

12 December 2020

Urinary enoxacin concentration and excretion after a single dose

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses

1 reference

12 December 2020

The comparative pharmacokinetics of five quinolones

1 reference

12 December 2020

Ofloxacin pharmacokinetics in renal failure

1 reference

12 December 2020

Norfloxacin penetration into human renal and prostatic tissues

1 reference

12 December 2020

Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis

1 reference

12 December 2020

Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green

1 reference

12 December 2020

Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis

1 reference

12 December 2020

Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli

1 reference

12 December 2020

Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other quinolone carboxylic acids

1 reference

12 December 2020

Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function

1 reference

12 December 2020

The pharmacokinetics and tissue penetration of ofloxacin

1 reference

12 December 2020

Study of the cerebrospinal fluid penetrability of ofloxacin.

1 reference

12 December 2020

Enoxacin compared with cefoperazone for the treatment of experimental Enterobacter aerogenes endocarditis

1 reference

12 December 2020

Ciprofloxacin: multiple-dose pharmacokinetic and clinical results in patients with hypercrinic bronchopulmonary diseases

1 reference

12 December 2020

Analysis of amifloxacin in plasma and urine by high-pressure liquid chromatography and intravenous pharmacokinetics in rhesus monkeys

1 reference

12 December 2020

Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers

1 reference

12 December 2020

Penetration of ciprofloxacin into aqueous humor

1 reference

12 December 2020

Pharmacokinetics of norfloxacin in chronic renal failure

1 reference

12 December 2020

Pharmacokinetics of pefloxacin in renal insufficiency

1 reference

12 December 2020

Pharmacokinetics of three oral formulations of ciprofloxacin

1 reference

12 December 2020

Pefloxacin kinetics in cirrhosis

1 reference

12 December 2020

Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans

1 reference

12 December 2020

Tissue distribution of ciprofloxacin following oral and intravenous administration

1 reference

12 December 2020

[Effect of pH value and magnesium on the antibacterial activity of quinolone preparations]

1 reference

12 December 2020

Pharmacokinetics of intravenously administered ciprofloxacin

1 reference

12 December 2020

Diffusion of ofloxacin into the cerebrospinal fluid in patients with bacterial meningitis

1 reference

12 December 2020

The pharmacokinetics and serum and urine bactericidal activity of ciprofloxacin

1 reference

12 December 2020

Pharmacokinetics and sputum penetration of ciprofloxacin in patients with cystic fibrosis

1 reference

12 December 2020

Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers

1 reference

12 December 2020

Ciprofloxacin concentrations in bone and muscle after oral dosing

1 reference

12 December 2020

Penetration of ciprofloxacin into bronchial secretions

1 reference

12 December 2020

Enoxacin decreases the clearance of theophylline in man.

1 reference

12 December 2020

Intraprostatic concentration of ciprofloxacin and its activity against urinary pathogens

1 reference

12 December 2020

Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus

1 reference

12 December 2020

10.2165/00003088-198814020-00003

Identifiers

DOI

1 reference

PubMed ID

3282749

Dimensions Publication ID

13 September 2017

0 references

1 reference

PubMed ID

3282749